Annals of Cancer Therapy and Pharmacology: Immunotherapy Drug for Patients with HPV-Related Cancers

-
Immunotherapy Drug for Patients with HPV-Related Cancers
      Immunotherapy drugs shrank the tumors of some patients with advanced human papillomavirus (HPV)-related cancers. The drug, bintrafusp alfa (also called M7824), was designed to simultaneously bind to two target proteins—PD-L1 and TGF-beta—that help prevent the immune system from effectively attacking tumor cells.
             Human Papillomavirus slow-growing cancer can be found early with regular Pap smear, also called a Pap test, a procedure in which cells are scraped from the cervix and looked at under a microscope. Mortality rates have been decreasing in the United States, thanks largely to the widespread use of the Pap smear as a screening tool. In addition to the Pap smear, DNA tests can also detect HPV strains that pose a cervical cancer risk. Cervical cancer incidence and mortality, however, remain significantly higher in low-income countries.
       Symptoms of this disease often go undetected until cancer becomes invasive. Abnormal vaginal bleeding is the most common sign of cervical cancer.
      Patients with advanced cancers, including cervical cancer, anal cancer, and squamous cell carcinoma of the head and neck. Most of the patients had tumors that tested positive for HPV.
       Among all participants, patients responded to the drug (their tumors shrank) Exit Disclaimer. Of the 36 patients with HPV-positive tumors, patients responded.
Four of the responses lasted longer than 18 months, and 11 out of 15 responses were still ongoing when the data were analyzed. Two patients showed no detectable signs of cancer following treatment.
         The survival of 9 to 11 months seen in patients with HPV-related cancers in previous trials testing immune checkpoint inhibitors that target PD-1 or PD-L1.
       M7824 drug is a promising agent for patients with HPV-related cancers and may potentially benefit these patients’ more than traditional checkpoint therapies.

       The researchers saw responses in patients whose tumors were infected with a variety of carcinogenic HPV types, including HPV16 and HPV18, which are responsible for most HPV-related cancers. Patients who responded had various types of cancer, including squamous cell cervical cancer, cervical adenocarcinoma, squamous cell anal carcinoma, and squamous cell head and neck cancer.

Comments

Post a Comment

Popular posts from this blog

Hepatitis C Care Cascade In IV Drug Users: Scientific Journal of Gastroenterology and Hepatology (SJGH)- ISSN : 2641-5585

-
Image
Hepatitis C Care Cascade In IV Drug Users ONOMY Science  Scientific Journal of Gastroenterology and Hepatology   (SJGH) - ISSN:   2641-5585           Many people who are infected with the hepatitis C virus (HCV) remain undiagnosed and untreated. Although those born between 1946 and 1964 represent most of the population with  chronic  HCV infection,  persons who inject drugs (PWID) now make up the largest population of new cases of the disease. Up to 90% of all new HCV infections worldwide and at least 75% of those in the United States are attributed to the use of injected drugs.           An estimated 10 million PWID are infected with HCV worldwide, creating a significant infectious reservoir for the continued spread of this virus. Control of HCV infection among PWID will require targeted strategies to address the “HCV cascade of care”—enhancing diagnosis, linking individuals to HC...
Read more

Using Artificial Intelligence to Catch Irregular Heartbeats: American journal of Cardiology and Cardiovascular diseases (AJCCVD), ISSN 2641-2438

-
Image
ONOMY Science  American journal of Cardiology and Cardiovascular diseases (AJCCVD),  Open Access ISSN 2641-2438 Using Artificial Intelligence to Catch Irregular Heartbeats           Thanks to advances in wearable health technologies, it’s now possible for people to monitor their heart rhythms at home for days, weeks, or even months via wireless electrocardiogram (EKG) patches. In fact, my Apple Watch makes it possible to record a real-time EKG whenever I want. (I’m glad to say I am in normal sinus rhythm.) For true medical benefit, however, the challenge lies in analyzing the vast amounts of data—often hundreds of hours worth per person—to distinguish reliably between harmless rhythm irregularities and potentially life-threatening problems. Now, NIH-funded researchers have found that artificial intelligence (AI) can help. A powerful computer “studied” more than 90,000 EKG recordings, from which it “learned” to recognize patterns,...
Read more

Kidney Transplant Rejection: American journal of Nephrology & Therapeutics (AJNT): ISSN 2643-7007

-
Image
American journal of Nephrology & Therapeutics (AJNT): ISSN 2643-7007 Kidney Transplant Rejection          A kidney transplant can greatly improve the quality of life for people with kidney failure. But about 20% of donated kidneys are attacked and destroyed by the recipient’s immune system. Transplant rejection can happen despite daily treatments that suppress the immune system.          To help prevent rejection, doctors try to ensure that the recipient and donor are a good genetic match. This includes measuring a group of proteins found on the body’s cells called human leukocyte antigens (HLAs). HLAs help the immune system tell which cells belong to the body and which might belong to foreign invaders, such as bacteria. The more HLAs that match between a kidney donor and recipient, the more likely a transplant is to be successful. But even a kidney perfectly matched by HLAs can be rejected. This ha...
Read more